Low-Cost Photoreactor to Monitor Wastewater Pollutant Decomposition.

Actually, the quality of water is one of the most important indicators of the human environmental impact, the control of which is crucial to avoiding irreversible damage in the future. Nowadays, in parallel to the growth of the chemical industry, new chemical compounds have been developed, such as dyes and medicines. The increasing use of these products has led to the appearance of recalcitrant pollutants in industrial wastewater, and even in the drinking water circuit of our populations. The current work presents a photoreactor prototype that allows the performance of experiments for the decomposition of coloured pollutants using photocatalysis at the laboratory scale. The design of this device included the study of the photometric technique for light emission and the development of a software that allows monitoring the dye degradation process. Open-source hardware platforms, such as Arduino, were used for the monitoring system, which have the advantages of being low-cost platforms. A software application that manages the communication of the reactor with the computer and graphically displays the data read by the sensor was also developed. The results obtained demonstrated that this device can accelerate the photodegradation reaction in addition to monitoring the changes throughout the process.

Development of 'Lignin-First' Approaches for the Valorization of Lignocellulosic Biomass.

Currently, valorization of lignocellulosic biomass almost exclusively focuses on the production of pulp, paper, and bioethanol from its holocellulose constituent, while the remaining lignin part that comprises the highest carbon content, is burned and treated as waste. Lignin has a complex structure built up from propylphenolic subunits; therefore, its valorization to value-added products (aromatics, phenolics, biogasoline, etc.) is highly desirable. However, during the pulping processes, the original structure of native lignin changes to technical lignin. Due to this extensive structural modification, involving the cleavage of the ß-O-4 moieties and the formation of recalcitrant C-C bonds, its catalytic depolymerization requires harsh reaction conditions. In order to apply mild conditions and to gain fewer and uniform products, a new strategy has emerged in the past few years, named 'lignin-first' or 'reductive catalytic fractionation' (RCF). This signifies lignin disassembly prior to carbohydrate valorization. The aim of the present work is to follow historically, year-by-year, the development of 'lignin-first' approach. A compact summary of reached achievements, future perspectives and remaining challenges is also given at the end of the review.

One-Pot Cu/TiO2 Nanoparticles Synthesis for Trans-Ferulic Acid Conversion into Vanillin.

In this study, the co-synthesis of TiO2 and Cu metallic nanoparticles obtained via one-pot cost-efficient hydrothermal process has been addressed. Different nanocatalysts with Cu contents were characterized by X-ray diffraction, nitrogen porosimetry, scanning electron microscopy, and transmission electron microscopy. The TiO2 and Cu metallic nanoparticles were synthesized with copper loading up to one (Cu/Ti atomic ratio). Synthesized catalysts exhibited pore sizes in the mesoporous range and high surface areas above 150 m2/g. The particle size for TiO2 presented a homogeneous distribution of approximately 8 nm, moreover, Cu nanoparticles varied from 12 to >100 nm depending on the metal loading. The nanostructured materials were successfully tested in the conversion of trans-ferulic acid into vanillin under sustainable conditions, achieving the best performance for 0.3 Cu/Ti atomic ratio (70% vanillin yield).

Model independent determination of the gluon condensate in four dimensional SU(3) gauge theory.

We determine the nonperturbative gluon condensate of four-dimensional SU(3) gauge theory in a model-independent way. This is achieved by carefully subtracting high-order perturbation theory results from nonperturbative lattice QCD determinations of the average plaquette. No indications of dimension-two condensates are found. The value of the gluon condensate turns out to be of a similar size as the intrinsic ambiguity inherent to its definition. We also determine the binding energy of a B meson in the heavy quark mass limit.

Correction: Chaparro et al. Whey as an Alternative Nutrient Medium for Growth of Sporosarcina pasteurii and Its Effect on CaCO3 Polymorphism and Fly Ash Bioconsolidation. Materials 2021, 14, 2470.

The Editorial Office was made aware of an error in Figure S1 within the original publication [...].

Chemical transformations of glucose to value added products using Cu-based catalytic systems.

Cu nanoparticles have been supported by two types of aluminosilicate materials with and without Zn in their composition in view of their application in the microwave-assisted conversion of glucose to valuable products via tandem formic acid-promoted dehydration (to 5-hydroxymethylfurfural--HMF) and further selective hydrogenation to 5-methylfurfuryl alcohol (MFA). Results show that interesting selectivities (up to 60% to MFA or HMF) could be achieved after short times of reaction (typically 2-30 min) using Cu-containing nanomaterials. Zn was found to play an interesting role in the selectivity to reduced products, even if present in very small quantities (0.2 wt%).

Compelling evidence of renormalons in QCD from high order perturbative expansions.

We compute the static self-energy of SU(3) gauge theory in four spacetime dimensions to order α20 in the strong coupling constant α. We employ lattice regularization to enable a numerical simulation within the framework of stochastic perturbation theory. We find perfect agreement with the factorial growth of high order coefficients predicted by the conjectured renormalon picture based on the operator product expansion.

Whey as an Alternative Nutrient Medium for Growth of Sporosarcina pasteurii and Its Effect on CaCO3 Polymorphism and Fly Ash Bioconsolidation.

Whey in large quantities can cause environmental problems when discarded, because it reduces dissolved oxygen and aquatic life. Nonetheless, it could be used as an easily available and economical alternative to reduce culture medium costs in microbially induced calcium carbonate precipitation (MICP). In this work, a native Sporosarcina pasteurii was isolated and then cultured by using different proportions of whey (W) in nutrient broth (NB). The solids were characterized by XRD, FT-IR, TGA, and SEM. The potential applications in bioconsolidation were also studied. Whey concentration was directly related to CaCO3 production. Higher whey concentrations reduced calcium carbonate purity to nearly 80%. All experiments showed calcite and vaterite fractions, where a whey increment in the media increased calcite content and decreased vaterite content, causing a decrease in crystal size. MICP improved compressive strength (CS) in sand and fly ash. The best CS results were obtained by fly ash treated with 25 W-75 NB (37.2 kPa) and sand with 75 W-25 NB (32.1 kPa). Whey changed crystal polymorphism in biogenic CaCO3 production. Material bioconsolidation depends on the CaCO3 polymorph, thus fly ash was effectively bioconsolidated by crystallization of vaterite and sand by crystallization of calcite.

Tuneable Acidity in Fluorinated Al-SBA-15 Materials for the Esterification of Valeric Acid to Alkyl Valerates.

The acidity of Al-SBA-15 materials functionalized by ball milling with several niobium loadings (0. 25-1 wt.%) as well as with several fluorine loadings (by wet impregnation using NH4F as a precursor) was characterized and materials investigated in the esterification of valeric acid to alkyl valerates. The parent Al-SBA-15 support as well as the modified materials loaded with Nb and/or F have been catalysts synthesized characterized by X-ray diffraction (XRD), N2 physisorption measurements, and diffuse reflection infrared spectroscopy (DRIFT) among others. A special interest was paid on the acidity of the materials that was investigated by temperature-programmed desorption of pyridine. Interestingly, the characterization results for the materials containing fluorine showed up an increase in the acidity strength despite of a reduction in the number of acid sites. The catalytic performance of the as-prepared catalysts was investigated in the microwave-assisted esterification reaction of valeric acid to valerate esters. Thus, while the materials modified with niobium exhibited a lower catalytic activity as compared with the catalytic support (Al-SBA-15), the materials loaded with fluorine either onto Al-SBA-15 or on Nb1%/Al-SBA-15 materials presented enhanced conversion values of valeric acid. Therefore, it can be said that the new acid sites with enhanced strength formed by the incorporation of fluorine boost the esterification of valeric acid with alcohols to form the respective valerate ester.

Synthesis and Characterization of Novel Pyridine Periodic Mesoporous Organosilicas and Its Catalytic Activity in the Knoevenagel Condensation Reaction.

The preparation of novel organic-inorganic hybrid mesoporous organosilica containing pyridinedicarboxamide functional groups uniformly distributed inside the nanostructured pore walls has been addressed. The mesoporosity and uniformity of the synthesized nanomaterials were characterized by different techniques such as nitrogen adsorption/desorption measurements and powder X-ray diffraction (PXRD). Additionally, the presence of the pyridinedicarboxamide in the pore walls of the nanomaterials was assessed by Fourier-transform infrared spectroscopy (FT-IR), as well as 29Si and 13C solid-state cross-polarization and magic angle spinning nuclear magnetic resonance (CP/MAS-NMR). The Knoevenagel condensation of aldehydes with active methylene compounds was carried out over the pyridinedicarboxamide functionalized mesoporous organosilica, which has been proven to be an efficient heterogeneous basic catalyst in the presence of ethanol as solvent. The catalytic activity of the investigated materials was investigated in the Knoevenagel condensation between malononitrile and several benzaldehyde derivatives exhibiting a high conversion (>90%) and excellent selectivity toward the final condensation products under very mild reaction conditions. Furthermore, the catalyst stability is noteworthy as it could be recycled and reused at least twelve times without any significant change in the performance.

Efficacy and safety of early treatment with sarilumab in hospitalised adults with COVID-19 presenting cytokine release syndrome (SARICOR STUDY): protocol of a phase II, open-label, randomised, multicentre, controlled clinical trial.

INTRODUCTION: About 25% of patients with COVID-19 develop acute respiratory distress syndrome (ARDS) associated with a high release of pro-inflammatory cytokines such as interleukin-6 (IL-6). The aim of the SARICOR study is to demonstrate that early administration of sarilumab (an IL-6 receptor inhibitor) in hospitalised patients with COVID-19, pulmonary infiltrates and a high IL-6 or D-dimer serum level could reduce the progression of ARDS requiring high-flow nasal oxygen or mechanical ventilation (non-invasive or invasive). METHODS AND ANALYSIS: Phase II, open-label, randomised, multicentre, controlled clinical trial to study the efficacy and safety of the administration of two doses of sarilumab (200 and 400 mg) plus best available therapy (BAT) in hospitalised adults with COVID-19 presenting cytokine release syndrome. This strategy will be compared with a BAT control group. The efficacy and safety will be monitored up to 28 days postadministration. A total of 120 patients will be recruited (40 patients in each arm). ETHICS AND DISSEMINATION: The clinical trial has been approved by the Research Ethics Committee of the coordinating centre and authorised by the Spanish Agency of Medicines and Medical Products. If the hypothesis is verified, the dissemination of the results could change clinical practice by increasing early administration of sarilumab in adult patients with COVID-19 presenting cytokine release syndrome, thus reducing intensive care unit admissions. TRIAL REGISTRATION NUMBER: NCT04357860.

Efficacy and safety of the combination of reduced duration prophylaxis followed by immuno-guided prophylaxis to prevent cytomegalovirus disease in lung transplant recipients (CYTOCOR STUDY): an open-label, randomised, non-inferiority clinical trial.

INTRODUCTION: Prolonged use of antivirals to prevent the development of cytomegalovirus (CMV) disease in lung transplant patients has been shown to have significant side effects, for which alternatives are being sought to reduce their use. The monitoring of cell immunity against CMV could be an alternative as it has shown to be useful in identifying transplant patients at low risk of infection, who could benefit from shorter prophylaxis. The aim of the CYTOCOR study is to demonstrate that the combination of a reduced prophylaxis strategy with subsequent CMV-specific immunological monitoring would allow CMV infection to be controlled in lung transplant patients as effectively as the usual strategy (prophylaxis followed by pre-emptive therapy), while reducing the side effects of antivirals due to the shorter duration of prophylaxis. METHODS AND ANALYSIS: Phase III randomised, open, multicentre, parallel, non-inferiority clinical trial to study the efficacy and safety of the combination of a prophylaxis strategy up to month +3 post-transplant followed by immuno-guided prophylaxis using the QuantiFERON-CMV technique up to month +12 post-transplant to prevent CMV disease in CMV-seropositive lung transplant recipients. This strategy will be compared with a combination of a usual prophylaxis strategy up to month +6 post-transplant followed by pre-emptive therapy up to month +12. To study the incidence of CMV disease, patients will be followed up to 18 months post-transplantation. A total of 150 patients are expected to be recruited for the study. ETHICS AND PUBLIC DISSEMINATION: The clinical trial has been approved by the Research Ethics Committees and authorised by the Spanish Agency of Medicines and Medical Devices (AEMPS).If the hypothesis of this clinical trial is verified, the dissemination of the results could change clinical practice by increasing knowledge about the safety and efficacy of discontinuing valganciclovir prophylaxis in lung transplant recipients. TRIAL REGISTRATION NUMBER: NCT03699254.

Visceral leishmaniasis in a rheumatoid arthritis patient receiving methotrexate. / Kala-azar en un paciente con artritis reumatoide tratada con metotrexato.

Patients with rheumatoid arthritis (RA) treated with disease-modifying antirheumatic drugs are susceptible to severe infections such as leishmaniasis. As L. infantum is endemic in the Mediterranean region, it is necessary to rule this infectious process out in any RA patient presenting with fever and pancytopenia. An early diagnosis based on a high suspicion can prevent a fatal outcome.

Heterogeneously catalyzed lignin depolymerization.

Biomass offers a unique resource for the sustainable production of bio-derived chemical and fuels as drop-in replacements for the current fossil fuel products. Lignin represents a major component of lignocellulosic biomass, but is particularly recalcitrant for valorization by existing chemical technologies due to its complex cross-linking polymeric network. Here, we highlight a range of catalytic approaches to lignin depolymerisation for the production of aromatic bio-oil and monomeric oxygenates.

[Analysis of the frequency of cardiac arrhythmias and conduction disturbances from a health-care perspective]. / Análisis de la frecuencia de las arritmias cardíacas y de los trastornos de conducción desde una perspectiva asistencial.

INTRODUCTION AND OBJECTIVES: Over the last few years, our understanding of the mechanisms underlying cardiac arrhythmias has increased substantially. However, few data on their prevalence exist. Our objectives were to analyze the prevalence of cardiac arrhythmias and conduction disturbances in cardiology clinic outpatients and to determine the number of patients with a class-I or -IIa recommendation for electrophysiological studies (EPS). PATIENTS AND METHOD: We investigated cardiac arrhythmias and conduction disturbances in 2045 patients and determined their prevalence in those seen for the first time. Specific conditions investigated included supraventricular and ventricular arrhythmias, ischemic disease with an ejection fraction (EF) <30%, second-degree or higher atrioventricular (AV) block, intraventricular block, and sick sinus syndrome. RESULTS: In total, 798 (39%) of all patients and 153 of the 704 (22%) seen for the first time presented with 1 or more of the specified conditions. Their distribution in all patients was: atrial fibrillation, 524 (26%); atrial flutter, 34 (2%); narrow-QRS tachycardia, 58 (3%); ventricular arrhythmias or EF<30% due to ischemic disease or both, 46 (2%); AV block or sinus dysfunction, 68 (3%); intraventricular block, 157 (8%); and other conditions, 4 (0.2%). Some 7% (143/2045) of all patients and 3.5% (25/704) of those seen for the first time had an indication for EPS. CONCLUSIONS: a) Almost 40% of all patients seen in a cardiology outpatient clinic and 1 in 4 of those seen for the first time presented with a cardiac arrhythmia or conduction disturbance; and b) more than 3% of patients seen for the first time had an indication for EPS.

Mother Behavior Q-Set (MBQS)Dimensionalidad del Q-set del comportamiento materno en muestras de México, Colombia y Uruguay / Mother Behavior Q-Set (MBQS): Dimensionality of the Mother Behavior Q-Set in samples from Mexico, Colombia and Uruguay

La sensibilidad se refiere a la capacidad del cuidador para percibir las señales del niño, interpretarlas correctamente y responder a ellas de manera contingente y apropiada. El Q Set del Comportamiento Materno (MBQS) fue creado a partir de descripciones teóricas y empíricas de la sensibilidad. Los Q-sorts se asocian con la metodología cuantitativa debido a que asignan puntajes; además, combinan la metodología cualitativa al hacer un estudio sistemático de la subjetividad. Son pocos los artículos que se ocupan de explorar el análisis, la validez interna, la confiabilidad o la replicabilidad externa de los Q-sorts. Usualmente los datos se reducen por medio de un análisis de componentes principales o análisis factorial. Sin embargo, en los Q-sorts se correlacionan los participantes para dilucidar las relaciones entre ellos en lugar de correlacionar las variables. El objetivo de la presente investigación fue encontrar evidencia respecto a la validez basada en la estructura interna del MBQS con el apoyo del software R y el paquete qmethod. Colaboraron 37 díadas mexicanas mamá-bebés, 35 colombianas y 24 uruguayas. En el 2002, Posada y colaboradores propusieron siete escalas. Las escalas en las que nuestro modelo factorial presentó un buen ajuste son las que tienen menos ítems, lo cual puede ser indicativo de que la falta de ajuste tiene que ver con la identificación del modelo debido a que se cuenta con pocas observaciones. Consideramos que tanto el uso del MBQS para evaluar la sensibilidad como del paquete qmethod para realizar el análisis resulta novedoso, relevante y pertinente

Sensitivity refers to the caregiver's ability to perceive infant's cues, interpret them correctly, and respond to them in a contingent and appropriate way. The Maternal Behavior Q Set (MBQS) was created from theoretical and empirical descriptions of sensitivity. Q-methodology is associated with the quantitative methodology because it assigns scores; in addition, it combines qualitative methodology by making a systematic study of subjectivity. Few papers are concerned with exploring the analysis, internal validity, reliability, or external replicability of Q studies. Usually analyses reduce data to a few summarizing factors, based on principal component analysis or centroid factor analysis. Q-factor analysis method was developed especially for q-sorted data; it is a by-person factor analysis which is used to identify groups of participants who make sense of a pool of items in comparable way. The aim of this study was to find evidence regarding the validity based on the internal structure of the MBQS using the R software and the qmethod package. Thirty-seven Mexican, 35 Colombian and 24 Uruguayan mother-baby dyads collaborated. In 2002, Posada et al. proposed seven scales. The scales in which our factorial model presented a good fit are those with the fewest items, which may be indicative that the lack of fit has to do with the identification of the model because there are few observations. We consider that both the use of the MBQS to assess sensitivity and the qmethod package to perform the analysis is novel, relevant and pertinent.

[Patterns of clinical presentation of atrial fibrillation in hospitalized patients]. / Patrones clínicos de presentación de la fibrilación auricular en los pacientes hospitalizados.

INTRODUCTION AND OBJECTIVES: The ACC/AHA/ESC 2001 guidelines for the management of atrial fibrillation (AF) establish 4 categories: first episode, paroxysmal, persistent and permanent. The aim of this study was to analyze the frequency of the different clinical patterns of presentation of AF in hospitalized patients. PATIENTS AND METHOD: We analyzed the pattern of AF in 300 hospitalized patients, 200 of whom were admitted to the cardiology and 100 to the internal medicine department. We determined the clinical profile and evaluated the factors influencing therapeutic management. RESULTS: The permanent form was present in 30% of the patients admitted to the cardiology department and in 51% if those admitted to the internal medicine department. The first episode pattern was the most frequent in cardiology department patients (41%). In patients hospitalized the in cardiology the percentage use of anticoagulants (57.9% vs. 41%; p < 0.01) and beta blockers was greater than in internal medicine patients, and digitalis use was lower. In the multivariate analysis, admission to the cardiology department was an independent predictor of treatment with beta blockers (OR = 3.8; 95% CI, 1.3-11.1; p < 0.05), and discharge from the hospital with AF was a predictor of anticoagulant prescription (OR = 4.8; 95% CI, 2.5-9.2; p < 0.001). CONCLUSIONS: a) Atrial fibrillation is an arrhythmia with a heterogeneous clinical pattern that varies depending on the type of care provided; b) on admission to cardiology, only 30% of the patients present with permanent arrhythmia, and the most frequent clinical pattern is first episode; and c) discharge from the hospital with AF was the principal determinant of therapeutic management.

[Changes in the clinical profile of patients treated with oral anticoagulants in the 1990's]. / Cambios en el perfil clínico de los pacientes anticoagulados durante la década de los noventa.

INTRODUCTION: During the last few years the efficacy of oral anticoagulant treatment in the prevention of thromboembolic complications among patients with cardiac diseases has been well established. This has determined an increase in the number of patients undergoing this therapy and a change in the clinical profile of these patients. OBJECTIVE: To determine the number and the changes in the clinical characteristics of patients treated with oral anticoagulants during the last decade. PATIENTS AND METHOD: The charts of 5,771 hospitalized patients between January 1, 1991 and December 31, 1999, were retrospectively reviewed. We analyzed the number of patients discharged with anticoagulant treatment, the clinical profile and the evolution during the decade. RESULTS: 761 (13.1%) patients were discharged with anticoagulants. The therapy was prescribed to 7.4% of the patients from 1991-1993 and to 15.1% of the patients from 1998-1999. The mean age of the patients was 60.4 from 1991-1993 and 67.1 from 1998-1999 (p < 0.001). At the beginning of the decade, 90% of the patients had prosthetic valves, suffered from rheumatic heart disease or had had thromboembolic phenomena previously. At the end of the decade, only 49% could be included in these groups. CONCLUSIONS: a) The use of oral anticoagulants among our hospitalized patients has been duplicated during the past ten years; b) the clinical profile has changed, patients are now older and with different morbidity; c) the rheumatic heart disease and the prosthetic valves are no longer the predominant indications, and d) the use of therapy as secondary prevention has decreased significantly.

Mechanochemical synthesis of maghemite/silica nanocomposites: advanced materials for aqueous room-temperature catalysis.

A simple, environmentally friendly, and highly reproducible protocol has been developed for the mechanochemical preparation of advanced nanocatalytic materials in a one-pot process. The materials proved to have unprecedented activities in aqueous Suzuki couplings at room temperature, paving the way for a new generation of highly active and stable advanced nanocatalysts.